Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 5Withdrawn 2Unknown 2Active not recruiting 2Terminated 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 10Gastrointestinal 6Head & Neck 5Thoracic 3Sarcoma 2Lymphoid 2Classical hematology 2Other hematologic neoplasm 1Gynecologic 1

Conditions

Leukemia, Myeloid, Acute 540Precursor Cell Lymphoblastic Leukemia-Lymphoma 313Hematologic Neoplasms 266Leukemia 179Myelodysplastic Syndromes 170Leukemia, Lymphocytic, Chronic, B-Cell 168Lymphoma 102Lymphoma, Non-Hodgkin 94Recurrence 86Neoplasms 84Multiple Myeloma 81Leukemia, Myelogenous, Chronic, BCR-ABL Positive 71Leukemia, Myelomonocytic, Chronic 61Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 58Burkitt Lymphoma 54Leukemia, Biphenotypic, Acute 48Myeloproliferative Disorders 45Lymphoma, Follicular 43Lymphoma, Mantle-Cell 42Lymphoma, Large B-Cell, Diffuse 42Hodgkin Disease 34Lymphoma, B-Cell 32Lymphoma, B-Cell, Marginal Zone 30Leukemia, B-Cell 30Anemia, Refractory, with Excess of Blasts 30Primary Myelofibrosis 27Leukemia, Plasma Cell 23Waldenstrom Macroglobulinemia 22Neoplasm, Residual 22Leukemia, Myeloid, Chronic-Phase 21

Interventions

Methotrexate 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Pathologic Complete Response × Other hematologic neoplasm × Clear all
NCT04314219 2025-03-13

PTCy-PMAT

King Faisal Specialist Hospital & Research Center

Phase 3 Recruiting
264 enrolled
LymphoidOther hematologic neoplasm

Pathologic Complete Response, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡